Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Am J Clin Pathol. 2012 Jul;138(1):122–129. doi: 10.1309/AJCP28LAOOKSZSVW

Figure 5.

Figure 5

Tissue staining and subsequent PCR-Pyrosequencing for KRAS

A. Case 1 with mutant KRAS codon 12 (c.35G>A) admixed with wild-type sequence. The assay was repeated 3 times on 120 DNA aliquot specimens (3 cases × 4 groups × 10 sections), and representative results are shown. There was no appreciable difference between DNA specimens from the four groups.

B. Case 3 with wild-type KRAS. The assay was repeated 3 times on 120 DNA aliquot specimens (3 cases × 4 groups × 10 sections), and representative results are shown. There was no appreciable difference between DNA specimens from the four groups.